Outpatient management of febrile neutropenia: Should we change the standard of care?

Oncologist

Volumn 2, Issue 6, 1997, Pages 365-373

  Talcott, James A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Fever; Neutropenia; Outpatient care; Practice guidelines; Risk assessment

Indexed keywords

ANTIBIOTIC AGENT; CARBENICILLIN; CEFALOTIN; CEFTAZIDIME; CYTOTOXIC AGENT; GENTAMICIN; OFLOXACIN;

ANTIBIOTIC THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG COST; DRUG FEVER; DRUG SAFETY; HEALTH CARE QUALITY; HEALTH ECONOMICS; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPENIA; ORAL DRUG ADMINISTRATION; OUTPATIENT CARE; PRIORITY JOURNAL; PSEUDOMONAS; QUALITY OF LIFE; RISK ASSESSMENT;

EID: 0031444394     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.2-6-365     Document Type: Article

References (16)

1. Bodey GP, Buckley M, Sathe YS et al. Quantitative relation-ships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328-340.
2. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 1995;4:293-307.
3. Schimpff S, Satterlee W, Young VM et al. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 1971;284:1061-1065.
4. Pizzo PA, Robichaud KJ, Gill FA et al. Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med 1979;67:194-200.
5. Pizzo PA, Robichaud KJ, Gill FA et al. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982;72:101-111.
6. DiNubile MJ. Therapeutic role of granulocyte transfusions. Rev Infect Dis 1985;7:232-243.
7. Wright DG. Symposium on infectious complications of neoplastic disease (Part II). Leukocyte transfusions: thinking twice. Am J Med 1984;76:637-644.
8. Pizzo PA, Robichaud KJ, Edwards BK et al. Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial. J Pediatr 1983;102:125-133.
9. Wade JC, Schimpff SC, Hargadon MT et al. A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. N Engl J Med 1981;304:1057-1062.
10. Wilson JM, Guiney DG. Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia. N Engl J Med 1982;306:16-20.
11. Gurwith MJ, Brunton JL, Lank BA et al. A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxa-zole in hospitalized granulocytopenic patients. Am J Med 1979;66:248-256.
12. Karp JE, Merz WG, Hendricksen C et al. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1987;106:1-7.
13. Cometta A, Calandra T, Bille J et al. Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia (Letter). N Engl J Med 1994;330:1240-1241 (see comments).
14. Crawford J, Ozer H, Stoller R et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 1991;325:164-170.
15. Gabrilove JL, Jakubowski A, Scher H et al. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 1988;318:1414-1422.
16. Ohno R, Tomonaga M, Kobayashi T et al. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N Engl J Med 1990;323:871-877.